PILL
(Nasdaq: PILL),
a healthcare information services company, today announced
physician-laboratory connectivity license agreements with A.O. Fox Memorial
Hospital, in Oneonta, New York; Holy Name Hospital, in Teaneck, New Jersey;
and Southwest Washington Medical Center, in Vancouver, Washington.
Under the terms of the agreements, ProxyMed will be installing the new
Windows version of its ClinScan laboratory product, which provides on-line
order processing and reporting of results between physician offices and the
hospitals' laboratories. ClinScan is utilized by more than 100 hospital and
commercial laboratories, which are connected to over 3,000 physicians. Also
as part of its strategy, ProxyMed intends to offer its ClinScan product
through ProxyNet, its national healthcare information network, as an EDI
transaction.
ProxyMed, Inc., based in Ft. Lauderdale, Florida, is a healthcare
information services company that provides on-line clinical and financial
electronic data interchange (EDI) services to physicians, nursing homes,
pharmacies, commercial and hospital laboratories, insurance companies and
managed care companies through its secure national healthcare information
network, ProxyNet.
Note: This News Release contains "forward-looking statements" within the
meaning of the federal securities laws. These forward-looking statements
include assumptions, beliefs and opinions relating to ProxyMed's growth
strategy based upon ProxyMed's interpretation and analysis of healthcare
industry trends and management's ability to successfully develop, implement,
market and sell its secure network transaction processing services, software
programs, clinical databases and financial transaction services to
physicians and other healthcare providers. This strategy assumes that
physicians will prefer "one-stop shopping" for its products and services and
that ProxyMed will be able to successfully develop, acquire, maintain and
upgrade competitive clinical and financial transaction sets and successfully
integrate them with ProxyMed's existing products and services. This
strategy also assumes that ProxyMed will be able to successfully develop and
execute its strategic relationships, especially with the providers of
information systems to physicians under ProxyMed's electronic commerce
partner program, and with pharmacy chains, independent pharmacy owners and
pharmacy information system vendors. Many known and unknown risks, |
